Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ManiMNICF 93 EV-to-EBIT is 13.26 as of Jul. 25, 2026, which is 36% below its 10-year median of 20.87. GuruFocus rates MNICF with a GF Score™ of 93/100 and a GF Value™ of $17.56. The stock has 2 warning signs investors should review. Among 465 Medical Devices & Instruments companies, Mani ranks better than 61.94% on this metric.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Mani's Enterprise Value is $780.4 Mil.
Mani's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 was $58.9 Mil. Therefore, Mani's EV-to-EBIT for today is 13.26.
The historical rank and industry rank for Mani's EV-to-EBIT or its related term are showing as below:
MNICF'
s EV-to-EBIT Range Over the Past 10 Years
Min: 10.72 Med: 20.87 Max: 59.66
Current: 14.24
During the past 13 years, the highest EV-to-EBIT of Mani was 59.66. The lowest was 10.72. And the median was 20.87.
MNICF's EV-to-EBIT is ranked better than 61.94% of 465
companies
in the Medical Devices & Instruments industry
Industry Median: 18.19
vs MNICF: 14.24
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Mani's Enterprise Value for the quarter that ended in Feb. 2026 was $1,115.9 Mil.
Mani's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $58.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mani EV-to-EBIT Related Terms
Mani EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Mani's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Mani's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mani EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Mani's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Mani's EV-to-EBIT falls into.
Mani's current Enterprise Value is $780.4 Mil.
Mani's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $58.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mani (MNICF) has a EV-to-EBIT of 13.26 as of Jul. 25, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Mani and its competitors. This is 36% below median its historical median of 20.87. Over the past decade, Mani's EV-to-EBIT has ranged from 10.72 to 59.66. According to the industry distribution chart, Mani ranks #177 out of 465 companies in the Medical Devices & Instruments industry, placing it in the top 38.1%.
Is Mani's EV-to-EBIT too high?
Mani's current EV-to-EBIT of 13.26 is 36% below median its 10-year median of 20.87. Over the past 10 years, this metric has ranged from a low of 10.72 to a high of 59.66. The Medical Devices & Instruments industry median EV-to-EBIT is 18.19. Mani's value of 13.26 is 27.1% below this industry median. Based on the distribution chart, Mani ranks #177 out of 465 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Mani has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does Mani's EV-to-EBIT compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Mani ranks #177 out of 465 companies for EV-to-EBIT. This puts Mani in the upper half of its industry. The industry median EV-to-EBIT is 18.19. Mani's value of 13.26 is 27.1% below this benchmark. Historically, Mani's own EV-to-EBIT has ranged from 10.72 to 59.66 over the past decade. While the company's 10-year median is 20.87 vs. the industry median of 18.19, Mani has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.19, based on 465 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mani's current EV-to-EBIT of 13.26 is 27.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Mani and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mani's current EV-to-EBIT is 13.26, which is 36% below median its own 10-year median of 20.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mani stock overvalued right now?
Mani (MNICF) has a current EV-to-EBIT of 13.26. The stock's GF Value™ is $17.56, compared to a current price of $12.82 — trading 27% below its estimated fair value. The current EV-to-EBIT is 13.26, which is 36% below median its 10-year median of 20.87 and 27.1% below the Medical Devices & Instruments industry median of 18.19. Mani's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Mani (MNICF), the current EV-to-EBIT is 13.26 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mani (MNICF) Overvalued in 2026?
Based on GuruFocus' analysis, Mani stock appears to be undervalued.
The current stock price of $12.82 is trading 27% below its estimated GF Value™ of $17.56.
Key valuation signals for MNICF:
EV-to-EBIT: 13.26 (36% below median its 10-year median of 20.87)
GF Value™: $17.56 vs. price of $12.82 (27% below fair value)
Industry Position: 27.1% below the Medical Devices & Instruments median (#177 of 465)
No single metric tells the full story. See the MNICF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mani Inc manufactures medical devices and dental instruments. It sells products in four categories: surgical instruments, ophthalmic instruments, suture needles, and dental instruments. Mani's surgical products include instruments such as staplers, vessel knives, and bone saws. Its ophthalmic instruments include a range of knives used during eye surgery and ophthalmic sutures. Mani's suture needles business includes a variety of taper point and cutting eyeless needles, which require suture attachment and sterilization by the customer, as well as stainless-steel eyed needles. The firm's dental instruments include endodontic instruments and accessories, root canal equipment, and finishing and polishing instruments.
93GF Score
Get the complete analysis for MNICF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MNICF has been successfully added to your 
